Summary & Overview
HCPCS C1714: Catheter, Transluminal Directional Atherectomy
HCPCS Level II code C1714 designates a catheter specifically engineered for transluminal directional atherectomy, a percutaneous endovascular technique to excise atherosclerotic plaque from arteries. This device-level code matters nationally because it maps to procedural supply use in peripheral vascular interventions and informs device billing, hospital outpatient claims, and device utilization tracking.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for transluminal directional atherectomy, standard sites of service, and device-level coding implications. The publication outlines typical payer coverage considerations and common claim modifiers used with device and procedure billing (provided in the input). It also summarizes what to expect in reimbursement reporting and device supply categorization across major payers.
This summary equips revenue cycle managers, device procurement teams, and clinical coding staff with the information needed to recognize HCPCS Level II code C1714, its clinical application, and the payer landscape nationally. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code C1714 represents a catheter used for transluminal directional atherectomy. This device is employed in endovascular procedures to remove atherosclerotic plaque from arterial lumen using a directional cutting mechanism.
Service type: Transluminal directional atherectomy, a percutaneous endovascular interventional procedure.
Typical site of service: Hospital outpatient department or ambulatory surgical center, where endovascular peripheral arterial interventions are performed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with symptomatic peripheral arterial disease (PAD) of the lower extremity presenting with lifestyle-limiting claudication or critical limb ischemia characterized by rest pain or nonhealing ischemic ulcer. The patient has focal, eccentric, or calcified atherosclerotic plaque in a femoropopliteal or infrainguinal artery identified by noninvasive testing (ABI, duplex ultrasound) and confirmed by diagnostic angiography. After diagnostic angiography demonstrates an accessible lesion suitable for endovascular therapy, the vascular surgeon or interventional cardiologist proceeds with a minimally invasive transluminal directional atherectomy using a specialized cutting or shaving catheter (C1714) to debulk plaque and restore lumen patency. The workflow typically includes pre-procedure consent and assessment, percutaneous arterial access (commonly common femoral artery), intraprocedural anticoagulation and imaging with fluoroscopic guidance, directional atherectomy device deployment and plaque excision, adjunctive balloon angioplasty or stent placement as indicated, hemostasis or closure device placement, and post-procedure monitoring in a recovery area with discharge planning that may include antiplatelet therapy and wound care if needed.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than typical for due to complexity (document increased work). |